01022-6/asset/a38873d9-5999-4e60-a3fc-c2fd1cbeca3d/main.assets/gr2_lrg.jpg)
cagrisema phase 3 results 2025 cagrilintide semaglutide obesity Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Incretin-based therapies for the treatment
Description
Use the logbook as evidence for your GP to increase your B12 if needed
Conversely, while a deficiency in Vitamin B12 may not cause weight gain, it can decrease energy levels and contribute to fatigue, making it harder to stay active and manage/maintain your weight properly
A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity
Your liver has to process all of that mobilized fat
